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Objective: The identification of stem cells (SC) remains challenging. In the human oral mucosal epithelium, these cells are believed to be in the basal layer (stem cell niche), 
but their exact location is unclear. The aim of this study was to examine the dysplastic oral 
epithelium for these SC-like proteins in order to assess their diagnostic value as biomarkers 
complementing the histological grading of dysplasia. Material and Methods: Thirty oral 
epithelial dysplasia (OED), 25 oral lichen planus (OLP), 10 oral hyperkeratosis and 5 normal 
oral epithelium (OE) were immunohistochemically examined for four SC markers [integrin 
β1, neuron-glial-2 (NG2), notch 1 (N1) and keratin 15 (K15)]. Results: Three of four SC 
markers were heterogeneously detected in all samples. K15 overexpression in the lower 
two-thirds of severe OED suggests an expanded SC niche. Integrin β1 distribution pattern 
was not measurably different between OEDs and control. NG2 was almost negative to 
absent in all samples examined. N1 expression was weak and highly variable in normal 
and dysplastic epithelium, making it an unreliable epithelial stem cell marker. Conclusions: 
Present findings suggest that these markers were unable to identify individual epithelial 
stem cells. Instead, subpopulations of cells, most probably stem cells and transit amplifying 
cells with stem cell-like properties were identified in the dysplastic oral epithelium. The 
characteristic expressions of K15 might be of diagnostic value for oral dysplasia and should 
be investigated further.
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INTRODUCTION 
Stem cells constitute a distinct subset of cells 
characterized by their capacity to self-renewal 
and differentiation into multi-lineage cellular 
constituents of a specific tissue or organ25. 
Although the phenotypic characteristics of these 
cells are not fully realized, their morphological 
features include small size, poor differentiation 
and primitive cytoplasm. These unique cells may 
undergo either symmetrical cell division, yielding 
two identical daughter stem cells, or asymmetrical 
cell division, to give rise to one daughter stem 
cell that replaces the original mother stem cell 
and a transit amplifying cell (TAC), which enters 
limited rounds of rapid cell division that increase 
their number, thereby preserving tissue integrity22. 
Stem cells are known to reside in specific locations 
known as stem cell niches12,22. In the human oral 
mucosal epithelium, stem cells are believed to be 
in the basal layer, but their exact localization has 
not been fully elucidated11.
Oral potentially malignant disorder (OPMD) is the 
term recommended by the World Health Organization 
Collaborating Center for Oral Cancer and Precancer 
Working Group over oral premalignant lesions and 
conditions as it indicates that not all lesions describe 
under this term may transform to cancer1,33. The 
most common OPMDs are leukoplakia, erythroplakia 
and oral lichen planus (OLP). Although the degree of 
epithelial dysplasia is generally used for assessing 
the risk of malignant transformation in OPMDs, 
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currently it is impossible to predict accurately which 
lesions would progress to malignancy30. For OLP, 
studies have reported varying rates of malignant 
transformation ranging from 0.5% up to 2.9%3. The 
role that stem cells play in the evolution of OPMDs 
and their progression is unclear.
The identification of stem cells remains 
challenging as they account for less than 1% of the 
adult cell population and their capacity to divide is 
diminished once they are removed from the body16. 
There are several ways to detect stem cells whether 
in vivo or in vitro. Stem cells are characterized by 
specific markers such as antigens, molecules and 
signaling pathways. A reliable marker is necessary 
to characterize these cells, and putative stem cell 
markers need to be assessed for their differential 
specificities in identifying this cellular subset. On the 
other hand, it is still unclear whether every marker-
positive cell has the property of a stem cell. In human 
epidermis, surrogate markers including keratins 15 
and 19, integrins α6 and β1, and p63 are highly 
expressed by the epidermal stem cells and early 
progenitor cells. These markers purportedly identify 
stem cell zone if not individual stem cells7,24,28. 
Whilst stem cells have been widely investigated 
at tissue sites including the skin7,14,15,21,24,27, central 
nervous system9 and cartilaginous tissues10, but 
much less is known about their characteristics 
in the oral epithelium13,17. The aim of this study 
was to determine the differential expression of 
four stem cell markers, namely integrin beta 1 
(β1), neuron-glial-2 (NG2), keratin 15 (K15) and 
notch 1 (N1) in the three constitutive tissue layers 
of dysplastic oral epithelium and compare their 
expression patterns with those of oral lichen planus 
(OLP), oral hyperkeratosis (OHK) and normal oral 
mucosa (NOM). The justification for choosing these 
four markers are: i) integrin β1, a component of 
integrin complexes, is expressed in high levels 
by epithelial stem cells13,14, ii) NG2, a chondroitin 
sulfate proteoglycan, is expressed by stem cells 
associated with interfollicular epidermis and hair 
follicles15, iii) N1 signaling is a direct determinant 
of stem cell fate in keratinocytes27, and iv) K15, an 
intermediate filament protein is expressed in hair 
follicle bulge stem cells20.
MATERIAL AND METHODS
Samples
The sample consisted of formalin-fixed paraffin-
embedded blocks of 30 cases of oral epithelial 
dysplasia (OED) [10 mild (Mi), 10 moderate (Mo), 
and 10 severe (Se)] 25 OLP and 10 OHK, retrieved 
from the archival records of the department of 
oral pathology. All these cases were reviewed by a 
qualified oral pathologist and selected according to 
the diagnostic criteria of the WHO1,33. Five cases of 
normal oral mucosa (NOM) were used as a control 
group.
Immunohistochemistry
Four commercially available antibodies, namely 
rabbit polyclonal antibody to integrin β1 (ab52971), 
notch 1 (ab27526) and keratin 15 (ab53116) 
(Abcam Inc., Cambridge, MA, USA), and rabbit 
monoclonal [LHM2] to NG2 (ab20156) (Abcam Inc., 
Cambridge, MA, USA) were obtained.
For immunohistochemistry, 4 µm-thick sections 
were prepared from the formalin-fixed paraffin-
embedded blocks and mounted on salinized slides. 
These sections were deparaffinized, rehydrated, 
immersed in citrate buffer (pH6), heated in a 
scientific microwave oven (H2850 Microwave 
Processor, EB Sciences Inc., East Granby, CT, USA) 
for 10 min at 99°C for antigen retrieval, and were 
allowed to cool down at room temperature before 
blockade of endogenous peroxidase with 3% 
hydrogen peroxide in methanol for 10 min. The 
sections were then incubated with the optimally 
diluted primary antibodies [integrin β1 (1:100), 
NG2 (1:400), N1 (1:200) and K15 (1:200)] for 30 
min at room temperature. An Envision kit (Dako 
REAL Envision Detection System, Peroxidase/
DAB+Rabbit/Mouse, Dako Corporation, Carpinteria, 
CA, USA) was used for the incubation with the 
secondary antibody for 1 hour, then the peroxidase 
activity was allowed to develop by incubating the 
sections in diaminobenzidine (DAB) for 5 min. 
Sections were then counterstained with Harris’s 
haematoxylin. Positive and negative controls were 
used according to manufacturer’s instructions.
Immunohistochemical analysis
For assessment of immunoexpression, a 
semiquantitative method was performed by two 
operators who were calibrated. Immunoreactivity 
was categorized as negative (-) or positive (+). 
Positive staining was assigned when cytoplasmic, 
membranous or nuclear immunoreactivity could be 
identified in any number of cells. For each positive 
case, five fields (“hot spots”) were chosen according 
to the areas showing the most intense staining 
at 200x magnification. In each field, staining 
was evaluated according to the specific epithelial 
layers: stratum basale, spinosum or corneum. 
The intensity of staining was categorized as mild 
(+) when the stain was present in the focal areas 
(<25%); moderate (++) when the staining was 
evident in significant areas (25%-50%); and strong 
(+++) when the stain was present in predominant 
areas (>50%). Their mean percentage scores 
were obtained. Localization of staining was also 
categorized as cytoplasmic, membranous and/
or nuclear. Representative digital images were 
captured using the Olyvia DotSlide Virtual Slide 
Differential expression of stem cell-like proteins in normal, hyperplastic and dysplastic oral epithelium
2015;23(1):79-86
J Appl Oral Sci. 81
System (Olympus Imaging Inc., Tokyo, Japan).
RESULTS
The immunohistochemical results and distribution 
of cases (NOM, OHK, OLP, MiOED, MoOED and 
SeOED) according to their mean percentage scores 
for the four stem cell markers (integrin β1, NG2, N1 
and K15) in the three constitutive epithelial layers 
are detailed in Table 1 and illustrated in Figures 1-4.
Integrin β1
Integrin β1 was detected in nearly all cases of 
OLP, OHK, OED and NOM. (Table 1). Their distribution 
patterns were not measurably different between 
the test and control samples. Integrin β1 protein 
localization was cytoplasmic and nuclear. Positive 
expression for this protein was largely observed in 
the basal layer of the oral epithelium and to a lesser 
extent in the suprabasal keratinocytes (Figures 
1A-F). Two OED samples (1MoOED and 1 SeOED, 
10% of total) demonstrated moderate signaling for 
this biomarker in the spinous layer (Figures 1E, F) 
(Table 1).
NG2
NG2 was predominantly non-detectable in 
both test and control samples (Table 1). In those 
cases that expressed NG2 positivity, staining was 
generally weak and localized in the membrane and 
cytoplasm. Their distribution patterns and/or lack of 
immunoexpression are illustrated in Figures 2A-F.
Notch 1
N1 signal was weak and highly variable. Weak 
basal signal was detected in normal epithelium while 
a stronger basal-suprabasal signal was observed 
in moderate dysplastic tissue. In those cases that 
expressed N1 positivity, protein localization was 
predominantly cytoplasmic and membranous. Their 
patterns of distribution in the various epithelial 
layers were heterogeneous and not measurably 
Staining expression levels of stem cell-like protein markers (%)
Variables Integrin β1 Neuron-glia- 2 Notch 1 Keratin 15
- + ++ +++ - + ++ +++ - + ++ +++ - + ++ +++
NOM (n=5)
S. corneum 4(80) 1(20) 0 0 4(80) 1(20) 0 0 0 0 1(20) 4(80) 0 2(40) 1(20) 2(40)
S. spinosum 4(80) 1(20) 0 0 4(80) 1(20) 0 0 0 0 0 5(100) 2(40) 1(20) 0 2(40)
S. basale 0 0 4(80) 1(20) 4(80) 1(20) 0 0 3(60) 0 2(40) 0 0 1(20) 0 4(80)
OHK (n=10)
S. corneum 9(90) 1(10) 0 0 8(80) 2(20) 0 0 0 1(10) 0 9(90) 2(20) 5(50) 3(30) 0
S. spinosum 9(90) 1(10) 0 0 9(90) 1(10) 0 0 0 3(30) 1(10) 6(60) 3(30) 1(10) 1(10) 5(50)
S. basale 0 0 8(80) 2(20) 9(90) 1(10) 0 0 0 4(40) 1(10) 5(50) 0 4(40) 1(10) 5(50)
OLP (n=25)
S. corneum 25(100) 0 0 0 20(80) 4(16) 0 1(4) 0 4(16) 7(28) 14(56) 10(40) 10(40) 5(20) 0
S. spinosum 20(80) 5(20) 0 0 23(92) 1(4) 1(4) 0 1(4) 3(12) 3(12) 18(72) 5(20) 11(44) 6(24) 3(12)
S. basale 1(4) 1(4) 18(72) 5(20) 23(92) 2(8) 0 0 13(52) 3(12) 6(24) 3(12) 4(16) 5(20) 3(12) 13(52)
MiOED (n=10)
S. corneum 9(90) 1(10) 0 0 6(60) 3(30) 1(10) 0 1(10) 0 2(20) 7(70) 2(20) 2(20) 6(60) 0
S. spinosum 9(90) 1(10) 0 0 6(60) 4(40) 0 0 1(10) 0 3(30) 6(60) 0 4(40) 2(20) 4(40)
S. basale 0 1(10) 4(40) 5(50) 7(70) 3(30) 0 0 7(70) 1(10) 2(20) 0) 0 1(10) 2(20) 7(70)
MoOED (n=10)
S. corneum 9(90) 1(10) 0 0 7(70) 3(30) 0 0 1(10) 1(10) 1(10) 7(70) 1(10) 0 2(20) 7(70)
S. spinosum 9(90) 0 1(10) 0 7(70) 1(10) 1(10) 1(10) 3(30) 2(20) 1(10) 4(40) 0 3(30) 4(40) 3(30)
S. basale 0 1(10) 4(40) 5(50) 10(100) 0 0 0 8(80) 2(20) 0 0 3(30) 4(40) 0 3(30)
SeOED (n=10)
S. corneum 9(90) 1(10) 0 0 9(90) 1(10) 0 0 2(20) 3(30) 2(20) 3(30) 1(10) 8(80) 0 1(10)
S. spinosum 9(90) 0 1(10) 0 10(100) 0 0 0 6(60) 4(40) 0 0 1(10) 4(40) 1(10) 4(40)
S. basale 1(10) 1(10) 4(40) 4(40) 10(100) 0 0 0 10(100) 0 0 0 1(10) 1(10) 2(20) 6(60)
Table 1- Distribution of stem cell-like protein markers in normal oral mucosa (NOM), oral hyperkeratosis (OHK), oral lichen 
planus (OLP) and oral epithelial dysplasia (OED)
Mi = mild; Mo = moderate; Se = severe; S = Stratum;  - = negative staining; + = mild staining; ++ = moderate staining; +++ 
= strong staining.
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Figure 1- Integrin β1 distribution patterns in the various epithelial layers of normal oral mucosa (A), oral hyperkeratosis (B), 
oral lichen planus (C), mild oral epithelial dysplasia (D), moderate oral epithelial dysplasia (E) and severe oral epithelial 
dysplasia (F). Original magnification 100x (A, B); 200x (Inset A, Inset B, C, D, E, F)
Figure 2- Neuron-glia-2 (NG2) distribution patterns in the various epithelial layers of normal oral mucosa (A), oral 
hyperkeratosis (B), oral lichen planus (C), mild oral epithelial dysplasia (D), moderate oral epithelial dysplasia (E) and 
severe oral epithelial dysplasia (F). Original magnification 100x (A, B, C, D, E, F)
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Figure 3- Notch 1 (N1) distribution patterns in the various epithelial layers of normal oral mucosa (A), oral hyperkeratosis 
(B), oral lichen planus (C), mild oral epithelial dysplasia (D), moderate oral epithelial dysplasia (E) and severe oral epithelial 
dysplasia (F). Original magnification 100x (A, B, D); 200x (C, E, F)
Figure 4- Keratin 15 (K15) distribution patterns in the various epithelial layers of normal oral mucosa (A), oral hyperkeratosis 
(B), oral lichen planus (C), mild oral epithelial dysplasia (D), moderate oral epithelial dysplasia (E) and severe oral epithelial 
dysplasia (F). Original magnification 100x (B, E, E Inset); 200x (A, C, D, F)
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different between test and control (Figures 3A-F). 
Nuclear immunopositivity was most apparent in 
SeOED (Figure 4F).
Keratin 15
K15 was not detected in 4 (16%) cases of OLP, 
3 (30%) MoOED and 1 case (10%) of SeOED (Table 
1). In those cases that were positive for K15, protein 
localization was membranous and cytoplasmic. 
Their distribution patterns are shown in Figures 
4A-F. K15 immunoreactivity was predominantly 
detected in the basal cell zone in NOM, OHK and OLP 
whereas in OED, basal K15 immunopositivity tends 
to diminish with increasing grades of dysplasia.
DISCUSSION
Although numerous studies have demonstrated 
the presence of stem cells in a variety of diseased 
and normal tissues including the pancreas, colon, 
lung, brain, peripheral blood and prostate21, reports 
on these cells in oral epithelia are limited13,17. 
Furthermore, accurate identification of stem cells 
at this tissue site is not well-established. In the 
oral epithelium, the putative stem/progenitor cell-
related markers for characterizing epithelial stem 
cells include cytokeratin (K5/14, K15, K19)5,13,26, 
integrins (α2, α3, α6, β1 and β4)13,14, NG217 and 
N117. In this study, four stem cell-like markers 
(integrin β1, NG2, N1 and K15) were selected 
to examine the tissue layers of dysplastic oral 
epithelium for cells that expressed these proteins, 
taking into consideration their distribution patterns 
as it might reflect more accurately the effects of 
aberrant signalling activity on these tissues in 
general and on stem cells in particular. Results 
on their expression patterns were compared with 
those of OLP, non-dysplastic (OHK) and normal oral 
epithelium (NOM).
Integrin β1 belongs to the large integrin 
family of transmembrane glycoprotein adhesion 
receptors that mediate cell-matrix and cell-cell 
adhesion. In human epidermis, integrin β1 is an 
essential feature of epidermal stem cells12,14,19,25. 
In the present study, among the four stem cell-
like protein markers evaluated, integrin β1 was 
the most widely expressed in both test and control 
samples, being detected mainly in the basal layer. 
This distribution pattern corroborated a previous 
study in which integrin β1 was also preferentially 
localized in the basal layer of NOM, OHK and OLP17. 
It is a generally accepted idea that the stem cell 
niche for oral epithelial stem cells is in the basal 
layer11. Another noteworthy observation is that 
2 OED samples (moderate OED, n=1; severe 
OED, n=1; 10% of total) showed evidence of 
suprabasal (spinous) staining for this biomarker. 
However, further investigation will be needed 
to determine the significance of this finding in 
relation to possible expansion of the stem cell 
compartment in oral dysplasia. In bovine normal 
stratified squamous epithelium, β1 integrin is 
expressed by basal epithelial cells whereas in bovine 
papillomavirus-induced fibropapillomas, β1 integrin 
is over-expressed and aberrantly localized in the 
suprabasal layer6. Given these evidences and our 
current observation, we speculated that a shift or 
expansion of the stem cell niche from the basal to 
the suprabasal zone in dysplastic oral epithelium 
may have occurred6,11.
Neuron-glial-2 (NG2) is a transmembrane 
proteoglycan present in ol igodendrocyte 
progenitors9, chondroblast10 and osteoblasts10. In the 
present study, NG2 was generally underexpressed 
in both test and control specimens. Lack of 
immunoreactivity might be attributed to the fact 
that NG2 expression is mostly found in fetal and 
developing tissues, precisely in cells that represent 
an intermediate transitional stage between stem 
cell progenitors and fully differentiated cells such 
as oligodendrocyte precursor cells (OPC) in human 
central nervous system9. This unique transitional 
character of OPC may not exist in oral epithelial 
progenitor cells. However, NG2 was reported 
to be expressed outside the nervous system 
including skin15, as well as in many tumors such 
as chondrosarcomas18 and melanomas4. In this 
study, nearly all samples were NG2-negative. In a 
few cases, the observed weak NG2 positivity in the 
suprabasal and corneum layers differed from an 
earlier report16 in which NG2 was mostly expressed 
within the basal layer. Our present observation 
seems to suggest the presence of TACs in these 
layers rather than in the basal layer which might 
be colonized by stem cells. This interpretation was 
based on the fact that NG2 is mostly expressed by 
cells that have made an initial commitment to a 
particular cellular lineage9.
K15 is a marker of hair follicle stem cells20 and is 
also expressed in basal epidermal keratinocytes26. 
The positive identification of K15 in the basal layer 
of both normal and test samples suggests that this 
protein molecule is also a marker for oral epithelial 
stem cells. K15 localization in the cytoplasm is 
an expected outcome because keratins usually 
form intermediate filament networks that are 
further developed into a dense and highly dynamic 
cytoskeleton spanning between the nucleus and 
the cell membrane5,20,26. It is a generally accepted 
idea that the stem cell niche for oral epithelial stem 
cells is in the basal layer11. Our current observation 
of K15 overexpression in the basal layer, with 
aberrant overexpression and localization in the 
spinous layer of higher grades of OEDs, suggests 
an expansion of the stem cell niche from the basal 
to the suprabasal zone11. In arsenic-induced skin 
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cancers, K15 increased expression was purportedly 
indicative of emergence of cancer stem cells31. On 
the other hand, another report found that poorly 
differentiated SCCs and SeOED are generally 
associated with a reduction or total loss of primary 
keratins (K5, K14 and K15)2. This reduction in 
expression is believed to be the cause of impaired 
desmosome formation with subsequent adhesion 
loss and increase in migratory propensity that is 
associated with these pathological disorders8.
Notch signaling is an evolutionarily conserved 
pathway that regulates numerous cellular processes 
including self-renewal of normal stem cells31. In 
mammals, there are four notch receptors. Altered 
notch signaling is known to affect the function 
of a variety of mammalian stem cells including 
those from marrow, skin and intestine, while 
deregulation of notch signaling has been implicated 
in tumor development and progression32. In 
normal squamous epithelium, N1 is predominantly 
expressed by basal cells but is downregulated in 
neoplasms of squamous origin23,29. Our current 
observations of weak and highly variable N1 signals 
in normal and dysplastic oral epithelium suggest 
that this protein is unreliable as a marker for 
epithelial stem cells.
In conclusion, this study demonstrated that 
subpopulations of cells with stem cell-like properties 
were identified in the dysplastic oral epithelium. 
However, these markers were unable to identify 
individual stem cells. The characteristic expression 
of K15 might be of diagnostic value for oral dysplasia 
and should be investigated further.
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